ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


Secondary Hyperparathyroidism in
Chronic Kidney Disease: Clinical
Consequences and Challenges
(Vol 31/No. 2. On-line test expires: 04/20/2006)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Maureen Michael, BSN, MBA, CHN
 Maureen Michael, BSN, MBA, CHN, is Executive Director of Central Florida Kidney Centers, Inc., Orlando, FL, and a member of the NKF-K/DOQI™ Steering Committee. She is a member of ANNA's Sunshine Central Chapter.
Donna Garcia, RD, LD/N
 Donna Garcia, RD, LD/N, is Renal Dietitian, Central Florida Kidney Centers, Inc., Orlando, FL.
  OUTLINE

Secondary hyperparathyroidism, a characteristic manifestation of chronic kidney disease (CKD), arises from a series of abnormalities in the interrelated cascade that controls bone and mineral metabolism. Although bone disease is the most recognized consequence of secondary hyperparathyroidism (HPT), it also precipitates a series of potentially devastating effects on the cardiovascular, nervous, endocrine, and erythropoietic systems. Optimal management of secondary hyperparathyroidism should allow control of serum parathyroid hormone levels while preventing hyperphosphatemia, maintaining normal calcium levels, and providing adequate vitamin D supplementation. Current therapeutic approaches are frequently unsuccessful in achieving these goals and may, in fact, exacerbate risk factors that increase morbidity and mortality in the dialysis population. Development of new therapeutic approaches may provide improved control of secondary hyperparathyroidism in the future.

  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.8 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910.

  EDUCATIONAL OBJECTIVES

Goal:
To discuss the effects of secondary hyperparathyroidism (HPT) on the entire body.

 Objectives:
1. List the potential adverse clinical outcomes related to inadequately controlled parathyroid hormone levels.
2. Describe the pathophysiology of secondary hyperparathyroidsim.
3. Discuss current therapeutic interventions and newer therapeutic approaches to treatment of secondary hyperparathyroidism.

AUTHOR DISCLOSURE STATEMENT
Maureen Michael has no conflicts of interest to disclose.
Donna Garcia has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.